Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26. 2, 12q13. 13 and 20q13. 33
…, B Olver, A Walther, RA Barnetson, M Churchman… - Nature …, 2010 - nature.com
Genome-wide association studies (GWAS) have identified ten loci harboring common
variants that influence risk of developing colorectal cancer (CRC). To enhance the power to …
variants that influence risk of developing colorectal cancer (CRC). To enhance the power to …
[HTML][HTML] Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label …
…, B Slomovitz, P Hanjani, J Farley, M Churchman… - The Lancet, 2022 - thelancet.com
Background Low-grade serous carcinoma of the ovary or peritoneum is characterised by
MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high-grade …
MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high-grade …
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer
…, F Elliott, J Lowery, CF Taylor, M Churchman… - Cancer research, 2010 - AACR
Radical radiotherapy and surgery achieve similar cure rates in muscle-invasive bladder cancer,
but the choice of which treatment would be most beneficial cannot currently be predicted …
but the choice of which treatment would be most beneficial cannot currently be predicted …
[HTML][HTML] The molecular origin and taxonomy of mucinous ovarian carcinoma
…, M Christie, YE Chiew, M Churchman… - Nature …, 2019 - nature.com
Mucinous ovarian carcinoma (MOC) is a unique subtype of ovarian cancer with an uncertain
etiology, including whether it genuinely arises at the ovary or is metastatic disease from …
etiology, including whether it genuinely arises at the ovary or is metastatic disease from …
Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.
5502 Background: HGSOC is a histopathological diagnosis and may represent multiple
diseases at a molecular level. We investigated whether distinct molecular subgroups may …
diseases at a molecular level. We investigated whether distinct molecular subgroups may …
[HTML][HTML] Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
…, JP Thomson, B Stanley, M Churchman… - Nature …, 2020 - nature.com
Endometrioid ovarian carcinoma (EnOC) demonstrates substantial clinical and molecular
heterogeneity. Here, we report whole exome sequencing of 112 EnOC cases following …
heterogeneity. Here, we report whole exome sequencing of 112 EnOC cases following …
Analysis of genetic and phenotypic heterogeneity in juvenile polyposis
K Woodford-Richens, S Bevan, M Churchman… - Gut, 2000 - gut.bmj.com
BACKGROUND Juvenile polyposis syndrome (JPS) is characterised by gastrointestinal (GI)
hamartomatous polyposis and an increased risk of GI malignancy. Juvenile polyps also …
hamartomatous polyposis and an increased risk of GI malignancy. Juvenile polyps also …
Molecular subclasses of clear cell ovarian carcinoma and their impact on disease behavior and outcomes
Purpose: To identify molecular subclasses of clear cell ovarian carcinoma (CCOC) and assess
their impact on clinical presentation and outcomes. Experimental Design: We profiled 421 …
their impact on clinical presentation and outcomes. Experimental Design: We profiled 421 …
[HTML][HTML] Therapeutic options for mucinous ovarian carcinoma
…, DDL Bowtell, M Christie, YE Chiew, M Churchman… - Gynecologic …, 2020 - Elsevier
Objective Mucinous ovarian carcinoma (MOC) is an uncommon ovarian cancer histotype
that responds poorly to conventional chemotherapy regimens. Although long overall survival …
that responds poorly to conventional chemotherapy regimens. Although long overall survival …
[HTML][HTML] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
RL Hollis, I Croy, M Churchman, C Bartos, T Rye… - British journal of …, 2022 - nature.com
Background Ovarian carcinosarcoma (OCS) is an uncommon, biphasic and highly aggressive
ovarian cancer type, which has received relatively little research attention. Methods We …
ovarian cancer type, which has received relatively little research attention. Methods We …